Nektar Therapeutics (NKTR) Revenue (2016 - 2025)
Historic Revenue for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $11.8 million.
- Nektar Therapeutics' Revenue fell 5112.75% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.6 million, marking a year-over-year decrease of 3278.72%. This contributed to the annual value of $98.4 million for FY2024, which is 921.53% up from last year.
- As of Q3 2025, Nektar Therapeutics' Revenue stood at $11.8 million, which was down 5112.75% from $11.2 million recorded in Q2 2025.
- Nektar Therapeutics' Revenue's 5-year high stood at $29.2 million during Q4 2024, with a 5-year trough of $10.5 million in Q1 2025.
- In the last 5 years, Nektar Therapeutics' Revenue had a median value of $23.6 million in 2022 and averaged $21.9 million.
- Per our database at Business Quant, Nektar Therapeutics' Revenue plummeted by 5324.18% in 2021 and then skyrocketed by 2214.78% in 2024.
- Over the past 5 years, Nektar Therapeutics' Revenue (Quarter) stood at $25.0 million in 2021, then dropped by 11.94% to $22.0 million in 2022, then grew by 8.45% to $23.9 million in 2023, then rose by 22.15% to $29.2 million in 2024, then crashed by 59.59% to $11.8 million in 2025.
- Its last three reported values are $11.8 million in Q3 2025, $11.2 million for Q2 2025, and $10.5 million during Q1 2025.